This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
CNGB3 Gene Therapy (Athena)
Drug Names(s): CNGB3 gene therapy,
Description: Athena Vision is developing an adenovirus associated viral vector serotype 8 containing the human CNGB3 gene for the treatment of achromatopsia.
CNGB3 Gene Therapy (Athena) News
Pink Sheet India Proposes Safeguards For Gene Therapies
Additional information available to subscribers only: